HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Brouwer Selected Research

laniquidar (R101933)

5/2002Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.
7/2000Role of intestinal P-glycoprotein in the plasma and fecal disposition of docetaxel in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Brouwer Research Topics

Disease

9Rheumatoid Arthritis
07/2017 - 05/2009
6Neoplasms (Cancer)
02/2007 - 01/2000
3Inflammation (Inflammations)
08/2012 - 11/2009
3Ankylosing Spondylitis
05/2011 - 11/2009
2Fatigue
07/2014 - 04/2010
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2012 - 05/2009
2Diarrhea
05/2000 - 01/2000
1Weight Loss (Weight Reduction)
03/2021
1Body Weight (Weight, Body)
03/2021
1Takayasu Arteritis (Arteritis, Takayasu's)
12/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1Autoimmune Diseases (Autoimmune Disease)
03/2014
1Sjogren's Syndrome (Sjogren Syndrome)
02/2014
1Immune System Diseases (Immune Disorders)
08/2012
1Lupus Nephritis
08/2012
1Periodontitis
04/2012
1Osteoporosis
05/2011
1Bone Resorption
05/2011
1Metabolic Bone Diseases (Osteopenia)
05/2011
1Serum Sickness
04/2010
1Systemic Vasculitis
05/2009
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
05/2009
1Glioma (Gliomas)
02/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2003
1Sleepiness
05/2002

Drug/Important Bio-Agent (IBA)

4AntibodiesIBA
01/2018 - 09/2010
3Cisplatin (Platino)FDA LinkGeneric
03/2003 - 01/2000
2Adalimumab (Humira)FDA Link
01/2018 - 11/2009
2Peptides (Polypeptides)IBA
03/2015 - 05/2011
2Rituximab (Mabthera)FDA Link
02/2014 - 04/2010
2AutoantibodiesIBA
09/2010 - 05/2009
2laniquidar (R101933)IBA
05/2002 - 07/2000
2Topotecan (Hycamtin)FDA LinkGeneric
01/2002 - 05/2000
2Paclitaxel (Taxol)FDA LinkGeneric
04/2001 - 06/2000
1CreatinineIBA
03/2021
1Neutralizing AntibodiesIBA
01/2018
1Infliximab (Remicade)FDA Link
01/2018
1acetyl 4-aminosalicylic acidIBA
07/2017
1Proteins (Proteins, Gene)FDA Link
07/2017
1Abatacept (Orencia)FDA Link
07/2014
1MicroRNAs (MicroRNA)IBA
03/2014
1Interleukin-4 (Interleukin 4)IBA
12/2013
1Granzymes (Granzyme)IBA
03/2013
1InterleukinsIBA
10/2012
1Interleukin-15 (Interleukin 15)IBA
10/2012
1Advanced Glycation End ProductsIBA
08/2012
1Receptor for Advanced Glycation End ProductsIBA
08/2012
1Pharmaceutical PreparationsIBA
04/2012
1ASK8007 monoclonal antibodyIBA
02/2012
1OsteopontinIBA
02/2012
1Vitamin DFDA LinkGeneric
05/2011
1ProcollagenIBA
05/2011
1C-Reactive ProteinIBA
05/2011
1Biomarkers (Surrogate Marker)IBA
05/2011
1OsteocalcinIBA
05/2011
1Collagen Type I (Type I Collagen)IBA
05/2011
125-hydroxyvitamin DIBA
05/2011
1Rheumatoid FactorIBA
04/2010
1Transcription Factors (Transcription Factor)IBA
11/2009
1Peptide Hydrolases (Proteases)FDA Link
05/2009
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2009
1Myeloblastin (Proteinase 3)IBA
05/2009
1SuspensionsIBA
02/2007
1Etoposide (VP 16)FDA LinkGeneric
03/2003
1Docetaxel (Taxotere)FDA Link
07/2000
1cremophor ELIBA
06/2000
1Irinotecan (Camptosar)FDA LinkGeneric
01/2000

Therapy/Procedure

3Therapeutics
12/2020 - 03/2003
1Fat-Restricted Diet (Diet, Fat Restricted)
03/2021
1Intravenous Infusions
01/2000